Effects of Personalized Dietary Advice on Health Status of Diabetes Type 2 Patients
NCT ID: NCT02381119
Last Updated: 2016-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2015-05-31
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study is to assess the effect of the Personalized Dietary Advice Services (PDAS) after a three month intervention on established markers of nutritional and health status in diabetes type 2 patients (HbA1c, glucose, insulin). Besides, the effect of the PDAS on perceived health status of diabetes type 2 patients will be assessed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Individualized Lifestyle Intervention in Subjects With Prediabetes
NCT01947595
Lifestyle Interventions for Long Term Diabetes Control
NCT00364312
Study of a Diabetes Prevention Patient Activation Clinical Decision Support Tool
NCT06358261
Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria
NCT00320008
Computer-assisted Diabetes Self-management Interventions
NCT00006163
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The dietitian will provide this personalized dietary advice, during the regular patient visits. In the control group, the dietitian will give the regular dietary advice.
The study will start with a run-in period of two weeks, during which baseline measures will be done. After the run-in period, the three-month study will start with a first dietary consult during which the dietitian will use the personalized dietary advice services for providing dietary advice in the experimental group.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Personalized advice
Dietitian provides Personalized dietary advice (based on genetic, blood and food intake profiles) (the type of advice is the intervention)
Personalized Dietary Advice Services
This Personalized Dietary Advice is based on markers for nutrition status and SNPs (single nucleotide polymorphisms).
This advice is given via Personalized Dietary Advice Services, in which health data of the client can be entered and will be translated into advice on intake of specific nutrients or food categories.
Regular care
Dietitian provides regular care for diabetes type 2 (regular advice is the control condition)
Regular care
The control group will receive usual advice for diabetes type 2 from the dietician. However, after the end of the study participants in the control group will be offered the opportunity to receive the Personalized Dietary Advice from their dietician, as based on the parameters measured during the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Personalized Dietary Advice Services
This Personalized Dietary Advice is based on markers for nutrition status and SNPs (single nucleotide polymorphisms).
This advice is given via Personalized Dietary Advice Services, in which health data of the client can be entered and will be translated into advice on intake of specific nutrients or food categories.
Regular care
The control group will receive usual advice for diabetes type 2 from the dietician. However, after the end of the study participants in the control group will be offered the opportunity to receive the Personalized Dietary Advice from their dietician, as based on the parameters measured during the study.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable BMI 25-35 kg/m2
* Diabetes type 2 as diagnosed by the General Practitioner (GP), based upon:
* Fasting glucose \> 6.9 mmol/l on two different days or one measurement of non-fasting glucose \> 11.0 mmol/l in combination with symptoms of hyperglycemia
* Healthy as assessed by the health and lifestyle questionnaire (P9607 F02; in Dutch);
* Voluntary participation;
* Informed consent signed;
* Willing to comply with the study procedures;
* Willingness to share pseudonymized data on food intake with external party MijnEetmeter (food intake app provider)
* Willingness to share pseudonymized data on physical activity with external party Medisana (provider of activity tracker)
* Willingness to share pseudonymized data on food intake, blood glucose, blood cholesterol, blood pressure, physical activity and body weight with the Nutrition Research Cohort (NRC) database
* Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data for 15 years.
* Have a desktop or laptop with internet access at home.
Exclusion Criteria
* Use of insulin or Sulfonyl Urea derivatives;
* Slow onset type 1 diabetes;
* Diabetes occurring after several attacks of pancreatitis known as pancreatic diabetes;
* (Having a history of a) medical condition that might significantly affect the study outcome as judged by the medical investigator and health and life style questionnaire. This includes diabetes type 1, gastrointestinal dysfunction, diseases related to inflammation or allergy, or a psychiatric disorder;
* Following a medically prescribed diet, other than dietary advice for diabetes type 2;
* Use of nutritional supplements that could influence the study outcome, including vitamin supplements, fish oil and/or omega fatty acids;
* Physical, mental or practical limitations in using computers;
* Alcohol consumption \> 21 (women) - 28 (men) units/week;
* Reported unexplained weight loss or gain of \> 2 kg in the month prior to the pre-study screening;
* Recent blood donation (\< 1 month prior to the start of the study);
* Not willing to give up blood donation during the study;
* Not having a general practitioner;
* Personnel of TNO in Zeist and Soesterberg and their partners.
* Not willing to accept information-transfer concerning study participation, or health-related information, like laboratory results, findings at anamnesis or physical examination and eventual adverse events to and from the participant's general practitioner.
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vitas
UNKNOWN
SwissAnalysis
UNKNOWN
TNO
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
W.J. Pasman
Project leader Clinical studies
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diëtistenpraktijk Sylvia van Daalen
Arnhem, Gelderland, Netherlands
Diëtistenpraktijk Verhoeven & Bac
Barendrecht, South Holland, Netherlands
independent practice Willy Gilbert
Dordrecht, South Holland, Netherlands
Diëtistenpraktijk Jansen-Sloot
Gorinchem, South Holland, Netherlands
Diëtistenpraktijk Care & Cure
Hillegom, South Holland, Netherlands
Diëtistenpraktijk MirjaM - Leefstijl & Dieet
Sassenheim, South Holland, Netherlands
Diëtistenpraktijk Dieetistopsport
Zoetermeer, South Holland, Netherlands
Netherlands Organisation for Applied Scientific Research (TNO)
Zeist, Utrecht, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P9618
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.